Ficolin-2 Plasma Level Assesses Liver Fibrosis in Non-Alcoholic Fatty Liver Disease

Fibrosis is the strongest predictor for disease-specific mortality in non-alcoholic fatty liver diseases (NAFLD), but the need for liver biopsy limits its diagnosis. We assessed the performance of plasma ficolin-2 (FCN-2) as a biomarker of fibrosis identified by an in silico discovery strategy. Two...

Descripción completa

Detalles Bibliográficos
Autores principales: Giraudi, Pablo J., Salvoza, Noel, Bonazza, Deborah, Saitta, Carlo, Lombardo, Daniele, Casagranda, Biagio, de Manzini, Nicolò, Pollicino, Teresa, Raimondo, Giovanni, Tiribelli, Claudio, Palmisano, Silvia, Rosso, Natalia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8911336/
https://www.ncbi.nlm.nih.gov/pubmed/35269955
http://dx.doi.org/10.3390/ijms23052813

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8911336/
https://www.ncbi.nlm.nih.gov/pubmed/35269955
http://dx.doi.org/10.3390/ijms23052813

Ejemplares similares